impact of recent data on guidelines for management of her2-positive breast cancer
Published 9 years ago • 516 plays • Length 32:19Download video MP4
Download video MP3
Similar videos
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
31:21
novel therapeutics for breast cancer: her2 and triple negative disease; new pathways, targets
-
10:02
expert perspectives: cdk 4/6 inhibitors for er breast cancer: emerging data and future implications
-
22:48
adjuvant therapy of breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
20:13
advanced hormone receptor-positive breast cancer
-
1:57
impact of cdk4/6 inhibitors on hr-positive, her2-negative advanced breast cancer
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
46:00
advanced breast cancer: challenges in pathways development
-
20:42
early stage her2 breast cancer - dr. christy russell
-
59:05
updates in the management of her2 positive breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
8:31
#esmo21 expert video report on her2-positive early breast cancer
-
6:39
expert report on advances in the management of her2-negative and her2-low advanced breast cancer
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
4:31
study of atezolizumab with pertuzumab and trastuzumab in her2- positive metastatic breast cancer